Zinc monocysteine
单半胱氨酸锌
Report date: 2022/01/14 13:23:58
Base Information
Drug NameZinc monocysteine
Drug Alias Name +[9]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Eye InstituteTheriva Biologics Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Eye InstituteAdeona Pharmaceuticals IncTheriva Biologics Inc
Active IndicationsN/A
Inactive Indications +[5]
Other Information
ATC CodeN/A
Related LinksN/A